Tiziana Life Sciences annual ebitda
2016
2017
2018
2019
2020
2021
2022
2023
2024
Tiziana Life Sciences EBITDA Growth & History (TLSA)
Tiziana Life Sciences's calculated EBITDA was −$15.8M for fiscal 2024.
View full Tiziana Life Sciences company overviewTiziana Life Sciences annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | −$15.8M | $2.2M | — |
| 2023 | 2023-12-31 | −$18.0M | −$3.4M | — |
| 2022 | 2022-12-31 | −$14.6M | $12.8M | — |
| 2021 | 2021-12-31 | −$27.4M | $655,000 | — |
| 2020 | 2020-12-31 | −$28.0M | −$18.1M | — |
| 2019 | 2019-12-31 | −$9.9M | −$62,000 | — |
| 2018 | 2018-12-31 | −$9.9M | $626,000 | — |
| 2017 | 2017-12-31 | −$10.5M | −$612,000 | — |
| 2016 | 2016-12-31 | −$9.9M | — | — |
Tiziana Life Sciences quarterly ebitda
No reported data
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|
Tiziana Life Sciences ebitda trends
Over the last five reported fiscal years, Tiziana Life Sciences's ebitda decreased from −$9.9M to −$15.8M, a change of −$5.9M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tiziana Life Sciences filings at SEC.gov ↗